Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-04-10 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB Convocation-Press release et annexes.pdf
AGM Information Classification · 1% confidence The document is explicitly titled "CONVOCATION À L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES" (Notice of General Shareholders' Meeting) and details the agenda for an upcoming meeting scheduled for April 30, 2020. The agenda items include voting on the 2019 annual accounts, dividend approval, remuneration reports, renewal of director mandates, and approval of change-of-control clauses related to financing agreements. This content is the core material distributed to shareholders to inform them and solicit their votes for the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2020-04-10 French
UCB Oproeping-Press release en bijlagen.pdf
AGM Information Classification · 1% confidence The document is explicitly titled "OPROEPING TOT DE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Call for the General Meeting of Shareholders) and details the agenda items for a meeting scheduled for April 30, 2020. The agenda includes voting on the annual accounts, dividend approval, remuneration reports, board member re-elections, and specific corporate governance items related to shareholder approval (like change of control clauses). This content is the core material presented to shareholders to inform their voting decisions prior to or during the meeting. This aligns perfectly with the definition of materials shared during an Annual General Meeting (AGM). The code for AGM materials is AGM-R.
2020-04-10 Dutch
10-04-20-EN.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details 'Acquisitions of own shares' and 'Disposals of own shares' conducted by UCB SA/NV under its Share Repurchase Program 2020, referencing specific regulatory articles (Royal Decree). This activity directly corresponds to the definition of a company buying back or selling its own shares for corporate purposes, which aligns perfectly with the 'Transaction in Own Shares' category. Filing Type Code: POS (Transaction in Own Shares). The document length (4496 chars) is substantial enough to be the primary disclosure, not just an announcement of a report (RPA/RNS).
2020-04-10 English
10-04-20-FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat et Aliénation d'actions propres" (Share Repurchase and Disposal) and details transactions where UCB SA bought back its own shares (Rachat d'actions propres) and disposed of shares following employee option exercises (Aliénation d'actions propres) between April 3 and April 9, 2020. This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which maps precisely to the 'Transaction in Own Shares' category. The document is a regulatory announcement ('information réglementée') dated April 10, 2020, providing specific transaction details, not a general earnings release or a comprehensive annual/interim report. Therefore, the appropriate code is POS.
2020-04-10 French
10-04-20-NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (share repurchase) and disposed of shares related to employee incentive plans. This directly corresponds to the definition of 'Transaction in Own Shares'. The document is a formal announcement dated April 10, 2020, providing specific transaction details in tables, which is characteristic of a regulatory disclosure regarding share repurchases/issuance. The document length is relatively short (4676 chars) and functions as a direct announcement of these transactions, fitting the POS code perfectly.
2020-04-10 Dutch
20200403 UCB Acquisitions and disposals of own shares_ENG final.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details 'Acquisitions of own shares' and 'Disposals of own shares' conducted by UCB SA/NV under its Share Repurchase Program 2020, including specific transaction dates, volumes, and prices. This activity directly relates to the company managing its own equity capital structure through share buybacks and issuances related to employee incentive plans. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities.
2020-04-03 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.